COMPLETED

Home Alone: An Intervention for People With Cognitive Impairment Who Live Alone

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this clinical trial is to evaluate a program for adults who live alone and have some cognitive impairment (CI) to see if it is useful and acceptable. This program aims to help older adults with cognitive impairment who live alone to be engaged and active, as well as safe at home. The investigators want to see how useful this program is and how it can be improved. The specific aims are: * Specific Aim 1: Develop and Adapt Home Alone to Prepare for Pilot Testing. * Specific Aim 2: Pilot Test a Revised Version of Home Alone. Phase I participants will be asked to: * Participate for 3 months * Complete 3 surveys * Complete 7 1-hour meetings on a weekly basis with a coach * Complete a final interview Phase II participants will be asked to: * Participate for 6 months * Complete 3 surveys * Complete 7 1-hour meetings on a weekly basis with a coach * A sub-sample will be asked to complete a final interview

Official Title

Home Alone: Developing a Home-Based Intervention for People With Cognitive Impairment Who Live Alone

Quick Facts

Study Start:2023-04-15
Study Completion:2025-07-29
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:COMPLETED

Study ID

NCT05746390

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:55 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * 55 years of age or older
  2. * Lives alone in a non-residential setting
  3. * Either 1) provider diagnosis of MCI, 2) Montreal Cognitive Assessment by telephone (T-MoCA) score between 13 and 18, and/or 3) subjective endorsement of memory impairment on screening
  4. * Resides in the US
  5. * Demonstrates capacity to consent
  1. * Live in assisted living, a group care home, or similar residential setting that provides care and services
  2. * Are not English speaking
  3. * Are currently participating in any other type of service that provides one-to-one psychosocial consultation or independent living coaching
  4. * Have a new or worsening mental health condition and are not receiving ongoing treatment
  5. * Have not remained on a stable psychotropic medications dosage, such as antidepressants, anxiolytics, or anti-psychotics, for the prior three months
  6. * Are not willing/interested in participating or cannot actively participate in the intervention, per researcher discretion

Contacts and Locations

Principal Investigator

Joseph Gaugler, PhD
PRINCIPAL_INVESTIGATOR
University of Minnesota

Study Locations (Sites)

University of Minnesota
Minneapolis, Minnesota, 55455
United States

Collaborators and Investigators

Sponsor: University of Minnesota

  • Joseph Gaugler, PhD, PRINCIPAL_INVESTIGATOR, University of Minnesota

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-04-15
Study Completion Date2025-07-29

Study Record Updates

Study Start Date2023-04-15
Study Completion Date2025-07-29

Terms related to this study

Additional Relevant MeSH Terms

  • Cognitive Impairment
  • Dementia
  • Memory Loss